These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 218503)

  • 41. Humoral and cellular immunity to varicella-zoster virus: an overview.
    Arvin AM
    J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410
    [No Abstract]   [Full Text] [Related]  

  • 42. Preparation of varicella-herpes zoster immunoglobulin.
    Janot C; Stoltz JF; Avenard G; Perrier P; Schooneman F; Streiff F
    Transfusion; 1981; 21(6):732-4. PubMed ID: 6274067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.
    Schmidt NJ; Dennis J; Lennette EH
    Infect Immun; 1977 Mar; 15(3):850-4. PubMed ID: 192677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific IgM antibody in serum of patients with herpes zoster infections.
    Ross CA; McDaid R
    Br Med J; 1972 Dec; 4(5839):522-3. PubMed ID: 4566017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.
    Otani N; Yamanishi K; Sakaguchi Y; Imai Y; Shima M; Okuno T
    J Immunol Methods; 2012 Mar; 377(1-2):53-5. PubMed ID: 22261191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A longitudinal study of varicella-zoster virus infections in renal transplant recipients.
    Luby JP; Ramirez-Ronda C; Rinner S; Hull A; Vergne-Marini P
    J Infect Dis; 1977 Apr; 135(4):659-63. PubMed ID: 192807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of antibody to Varicella-Zoster virus by immune adherence hemagglutination.
    Gershon AA; Kalter ZG; Steinberg S; Kuhns WJ
    Proc Soc Exp Biol Med; 1976 Apr; 151(4):762-5. PubMed ID: 177988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody responses to varicella-zoster virus and the role of antibody in host defense.
    Gershon AA; Steinberg SP
    Am J Med Sci; 1981; 282(1):12-7. PubMed ID: 6267940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.
    Forghani B; Schmidt NJ; Dennis J
    J Clin Microbiol; 1978 Nov; 8(5):545-52. PubMed ID: 215602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections.
    Sundqvist VA; Linde A; Wahren B
    J Clin Microbiol; 1984 Jul; 20(1):94-8. PubMed ID: 6086711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral infection in acute peripheral facial palsy. Investigation in Yamagata Prefecture.
    Inamura H; Aoyagi M; Tojima H; Koike Y
    Acta Otolaryngol Suppl; 1988; 446():23-6. PubMed ID: 2844058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical immunological characteristics of herpes zoster].
    Smirnov IuK; Shishov AS; Mal'tseva NN
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Oct; (10):58-61. PubMed ID: 218405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors influencing the duration of treatment of acute herpetic pain with sympathetic nerve block: importance of severity of herpes zoster assessed by the maximum antibody titers to varicella-zoster virus in otherwise healthy patients.
    Higa K; Dan K; Manabe H; Noda B
    Pain; 1988 Feb; 32(2):147-157. PubMed ID: 2834685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutralization tests with varicella-zoster virus.
    Caunt AE; Shaw DG
    J Hyg (Lond); 1969 Jun; 67(2):343-52. PubMed ID: 4183291
    [No Abstract]   [Full Text] [Related]  

  • 55. Determination of infection and immunity to varicella-zoster virus with an enzyme-linked immunosorbent assay.
    Sirpenski SP; Brennan T; Mayo DR
    J Infect Dis; 1985 Dec; 152(6):1349. PubMed ID: 2999261
    [No Abstract]   [Full Text] [Related]  

  • 56. Detection of antibodies to varicella zoster virus by radioimmunoassay and enzyme immunoassay techniques.
    Friedman MG; Haikin H; Leventon-Kriss S; Joffe R; Goldstein V; Sarov I
    Med Microbiol Immunol; 1978 Nov; 166(1-4):177-86. PubMed ID: 82905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRUDE TISSUE CULTURE ANTIGEN FOR DETERMINATION OF VARICELLA-ZOSTER COMPLEMENT FIXING ANTIBODY.
    BRUNELL PA; CASEY HL
    Public Health Rep (1896); 1964 Sep; 79(9):839-42. PubMed ID: 14213793
    [No Abstract]   [Full Text] [Related]  

  • 58. Antigenic relationship between human cytomegalovirus, herpes simplex, and varicella-zoster virus studied by complement-fixation.
    Krech U; Jung M
    Arch Gesamte Virusforsch; 1971; 33(3):288-95. PubMed ID: 4329637
    [No Abstract]   [Full Text] [Related]  

  • 59. A practical method for preparation of varicella-zoster immune globulin.
    Zaia JA; Levin MJ; Wright GG; Grady GF
    J Infect Dis; 1978 May; 137(5):601-4. PubMed ID: 207788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Herpes zoster in patients with systemic lupus erythematosus].
    Kusaba T; Iwahashi T; Hayashida I; Nagasawa K; Hachimine K; Mayumi T
    Kansenshogaku Zasshi; 1987 Feb; 61(2):134-9. PubMed ID: 3039018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.